Ken Londoner, Chairman and CEO of BioSig Technologies, has recently announced company’s plans to resume its clinical activities with patient cases at Texas Cardiac Arrhythmia Institute at St. David’s Medical
Center in Austin, TX.
Ken Londoner has also shared that BioSig
Technologies is actively negotiating with a number of other centers in order to continue its clinical
activities and to initiate new
installations of its PURE EP(tm)
System.
